Browsing by Contributors Yamazaki, Shinji

فهرست الفبایی 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
آ ب پ ت ث ج چ ح خ د ذ ر ز ژ س ش ص ض ط ظ ع غ ف ق ک گ ل م ن و ه ی
 
Showing results 1 to 5 of 5
PreviewIssue DateTitleContributor(s)
2013medicine article a (537).pdf.jpg2013J. Jean Cui, * Hong Shen, Michelle Tran-Dube , ́ Mitchell Nambu, Michele McTigue, Neil Grodsky, Kevin Ryan, Shinji Yamazaki, Shirley Aguirre, Max Parker, Qiuhua Li, Helen Zou, and James ChristensenCui, J Jean; Shen, Hong; Tran-dube, Michelle; Nambu, Mitchell; Mctigue, Michele; Grodsky, Neil; Ryan, Kevin; Yamazaki, Shinji; Aguirre, Shirley; Parker, Max; Li, Qiuhua; Zou, Helen; Christensen, James
2012medicine article a (583).pdf.jpg2012J. Jean Cui, * Michele McTigue, Mitchell Nambu, Michelle Tran-Dube , ́ Mason Pairish, Hong Shen, Lei Jia, Hengmiao Cheng, Jacqui Ho ff man, Phuong Le, Mehran Jalaie, Gilles H. Goetz, § Kevin Ryan, Neil Grodsky, Ya-li Deng, Max Parker, Sergei Timofeevski,Cui, J Jean; Mctigue, Michele; Nambu, Mitchell; Tran-dube, Michelle; Pairish, Mason; Shen, Hong; Jia, Lei; Cheng, Hengmiao; Ho, Jacqui; Le, Phuong; Jalaie, Mehran; Goetz, Gilles H; Ryan, Kevin; Grodsky, Neil; Deng, Ya-li; Parker, Max; Timofeevski, Sergei; Murray, Brion W; Yamazaki, Shinji; Aguirre, Shirley; Li, Qiuhua; Zou, Helen; Christensen, James
2018 JMC Volume 61 Issue 3 February  (17).pdf.jpg2018Optimization of Orally Bioavailable Enhancer of Zeste Homolog 2 (EZH2) Inhibitors Using Ligand and Property-Based Design Strategies: Identification of Development Candidate (R)-5,8-Dichloro-7-(methoxy(oxetan-3-yl)methyl)-2-((4-methoxy-6-methyl-2-oxo-1,2-dKung, Pei Pei; Bingham, Patrick; Brooun, Alexei; Collins, Michael; Deng, Ya Li; Dinh, Dac; Fan, Connie; Gajiwala, Ketan S.; Grantner, Rita; Gukasyan, Hovhannes J.; Hu, Wenyue; Huang, Buwen; Kania, Robert; Kephart, Susan E.; Krivacic, Cody; Kumpf, Robert a.; Khamphavong, Penney; Kraus, Manfred; Liu, Wei; Maegley, Karen a.; Nguyen, Lisa; Ren, Shijian; Richter, Dan; Rollins, Robert a.; Sach, Neal; Sharma, Shikhar; Sherrill, John; Spangler, Jillian; Stewart, Albert E.; Sutton, Scott; Uryu, Sean; Verhelle, Dominique; Wang, Hui; Wang, Shuiwang; Wythes, Martin; Xin, Shuibo; Yamazaki, Shinji; Zhu, Huichun; Zhu, Jinjiang; Zehnder, Luke; Edwards, Martin
2011medicine article a (441).pdf.jpg2011Optimization of Potent , Selective , and Orally Bioavailable Pyrrolodinopyrimidine-Containing Inhibitors of Heat Shock Protein 90 . Identification of Development CandidateZehnder, Luke; Bennett, Michael; Meng, Jerry; Huang, Buwen; Ninkovic, Sacha; Wang, Fen; Braganza, John; Tatlock, John; Jewell, Tanya; Zhou, Joe Zhongxiang; Burke, Ben; Wang, Je; Maegley, Karen; Mehta, Pramod P; Yin, Min-jean; Gajiwala, Ketan S; Hickey, Michael J; Yamazaki, Shinji; Smith, Evan; Kang, Ping; Sistla, Anand; Dovalsantos, Elena; Gehring, Michael R; Kania, Robert; Wythes, Martin; Kung, Pei-pei
2011medicine article a (188).pdf.jpg2011Structure Based Drug Design of Crizotinib ( PF-02341066 ), a Potent and Selective Dual Inhibitor of Mesenchymal À Epithelial Transition Factor ( c-MET ) Kinase and Anaplastic Lymphoma Kinase ( ALK ) †Cui, J Jean; Tran-dub, Michelle; Shen, Hong; Nambu, Mitchell; Kung, Pei-pei; Pairish, Mason; Jia, Lei; Meng, Jerry; Funk, Lee; Botrous, Iriny; Mctigue, Michele; Grodsky, Neil; Ryan, Kevin; Padrique, Ellen; Alton, Gordon; Timofeevski, Sergei; Yamazaki, Shinji; Li, Qiuhua; Z